The second half of 2019 is in full swing, and August brought along a pair of critical announcements in the marijuana investment market.


The fallout from the scandal surrounding CannTrust Holdings (NYSE:CTST,TSX:TRST) continued as a provincial retailer decided to return all the product from the company.

Across the border in the US, a conversation between the Department of Justice (DOJ) and industry leading multi-state operators (MSOs) may offer a different perspective on the relationship between the federal agency and the cannabis market.

OCS returns all CannTrust marijuana

Last month, the Ontario Cannabis Store (OCS), a provincial distributor and store, elected to issue a return of product to troubled marijuana producer CannTrust Holdings.

This decision was born out of operational wrongdoings from CannTrust. In July, Health Canada, the country’s regulator for the cannabis industry, found that the company had been growing cannabis in unlicensed rooms at its Pelham, Ontario, facility.

CannTrust confirmed to the Investing News Network (INN) that all the product being returned by the OCS was produced in its unlicensed rooms.

In an email to INN, an OCS spokesperson said the decision to return the product was “consistent with the OCS’ obligation to operate its business in a responsible manner.”

During the month of August, shares of CannTrust continued to be affected by its problems. As of Wednesday (August 28), shares of the company in New York and Toronto were down by 23.39 percent and 22.65 percent, respectively.

Companies embrace DOJ interactions

As part of the quarterly earnings season, Charlie Bachtell, co-founder and CEO of Cresco Labs (CSE:CL,OTCQX:CRLBF), told investors that his company’s recent interactions with the DOJ ⁠— as part of an antitrust acquisition review ⁠— are a positive sign for the US marijuana space.

“The fact that a federal agency is reviewing (a mergers and acquisitions) transaction in this industry must be seen as validation,” Bachtell said during a call discussing Cresco Labs’ second quarter results.

“They are acknowledging the existence of this industry and running our transaction through the same process as traditional industries,” he said.

The Illinois-based MSO is attempting to complete its planned acquisition of Origin House (CSE:OH,OTCQX:ORHOF), a move designed to offer Cresco Labs a unique entry point into the California cannabis state program.

“It’s a new, emerging industry from their lens,” Josh Rosen, CEO of 4Front Ventures (CSE:FFNT,OTCQX:FFNTF), told INN as he faced a similar review.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: 4Front Ventures is a client of the Investing News Network. This article is not paid-for content.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less